IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.

Revenue
+8.00%
EPS
+10.2%
Free cash flow
−21.3%
Total debt
+7.42%

Quarter to September 2026, against a year earlier

271.68 6.80 +2.57%
Market cap
$43.7B
P/E
32.6×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a

IQVIA Holdings Inc. 10-Q filed Oct 28, 2025

Fiscal Q3 2025 · Period ended Sep 30, 2025 · Filed · accepted 4:31 PM ET · Document on sec.gov · Filing index

What changed

Part II, Item 1A, Risk Factors, against the 10-Q filed Jul 22, 2025: no material changes, the filing says